Compare FA & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FA | OMCL |
|---|---|---|
| Founded | 2003 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Computer Manufacturing |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.2B |
| IPO Year | 2021 | 2001 |
| Metric | FA | OMCL |
|---|---|---|
| Price | $13.29 | $46.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $19.00 | ★ $51.50 |
| AVG Volume (30 Days) | ★ 630.4K | 451.1K |
| Earning Date | 02-26-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $1,461,496,000.00 | $1,177,740,000.00 |
| Revenue This Year | $85.07 | $8.61 |
| Revenue Next Year | $5.03 | $4.30 |
| P/E Ratio | ★ N/A | $108.22 |
| Revenue Growth | ★ 93.41 | 10.67 |
| 52 Week Low | $11.95 | $22.66 |
| 52 Week High | $20.28 | $55.00 |
| Indicator | FA | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 41.58 |
| Support Level | $12.65 | $45.10 |
| Resistance Level | $14.20 | $50.14 |
| Average True Range (ATR) | 0.75 | 1.72 |
| MACD | -0.17 | -0.80 |
| Stochastic Oscillator | 32.86 | 18.25 |
First Advantage Corp is a provider of global software and data in the Human Resources technology industry. The company leverages proprietary technology and AI across its platforms, data, and APIs to deliver comprehensive background screening, digital identity, and verification solutions driven by innovation, automation, and customer success. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. Maximum revenue is generated from the First Advantage Americas segment. The group serves customers in over 200 countries and territories, modernising hiring and onboarding on a global scale.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.